{"url_path":"/sec/vtvt/8-k/2026-05-13/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1641489/0001193125-26-221971-index.html","accession_number":"0001193125-26-221971","cik":"0001641489","ticker":"VTVT","issuer_name":"vTv Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1641489/0001193125-26-221971-index.html","primary_entity_key":"0001641489","primary_entity_name":"vTv Therapeutics Inc."},"word_count":307,"has_tables":true,"body_markdown":"8-K\n\nNASDAQ false 0001641489 0001641489 2026-05-13 2026-05-13\n\n \n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\n \n\n \n\nFORM 8-K\n\n \n\n \n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d)\n\nof the Securities Exchange Act of 1934\n\nDate of Report (Date of earliest event reported): May 13, 2026\n\n \n\n \n\nvTv Therapeutics Inc.\n\n(Exact name of Registrant as specified in its charter)\n\n \n\n \n\n \n\nDelaware\n \n001-37524\n \n47-3916571\n\n(State or other jurisdiction\n\nof incorporation)\n\n \n\n(Commission\n\nFile Number)\n\n \n\n(I.R.S. Employer\n\nIdentification No.)\n\n3980 Premier Drive, Suite 110\n\nHigh Point, NC 27265\n\n(Address of Principal Executive Offices)\n\n(336) 641-0300\n\n(Registrant’s telephone number, including area code)\n\nNOT APPLICABLE\n\n(Former name or former address, if changed since last report)\n\n \n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):\n\n \n\n \n☐\n\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n \n☐\n\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n \n☐\n\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n \n☐\n\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class\n\n \n\nTrading\n\nSymbol(s)\n\n \n\nName of each exchange\n\non which registered\n\nClass A common stock, par value $0.01 per share\n \nVTVT\n \nNasdaq Capital Market\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.\n\n☐ Emerging growth company\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}